home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 1012      Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others

ORIGINAL ARTICLE

Levetiracetam versus fosphenytoin in pediatric convulsive status epilepticus: A randomized controlled trial

Handral Anusha, Veerappa Basavraja G, Gowda Vykuntaraju K, Shivappa Sanjay K, Benakappa Naveen, Benakappa Asha

Year : 2020| Volume: 15| Issue : 3 | Page no: 252-256

   This article has been cited by
 
1 Treatment of benzodiazepine-resistant status epilepticus: Systematic review and Network Meta-analyses
Puneet Jain, Satinder Aneja, Jessie Cunningham, Ravindra Arya, Suvasini Sharma
Seizure. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Recent updates on Levetiracetam
Gajanan Panchal, Salil Uppal, Shikhil Uppal
IP Indian Journal of Neurosciences. 2022; 8(1): 21
[Pubmed]  [Google Scholar] [DOI]
3 A Critical Review of Fosphenytoin Sodium Injection for the Treatment of Status Epilepticus in Adults and Children
Jordan L Clay, Nathan B Fountain
Expert Review of Neurotherapeutics. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Suresh Kumar Angurana, Renu Suthar
Journal of Tropical Pediatrics. 2021; 67(2)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article